Anteris Technologies Global vs Envoy Medical
AVR and COCH side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVR and COCH compare
Anteris Technologies Global and Envoy Medical are about the same size, with market caps of $556M and $534M.
Anteris Technologies Global grew revenue faster over the last twelve months (9.0% versus −6.8% for Envoy Medical).
Anteris Technologies Global keeps more of each dollar of sales as profit, with a net margin of −4637% compared with −11305% at Envoy Medical.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVR | COCH |
|---|---|---|
| Size and price | ||
| Market cap | $556M | $534M |
| Share price | $5.70 | $6.92 |
| Change, 1 year | 50.4% | 942% |
| Change, 5 years | – | −92.9% |
| Beta (5Y) | 1.57 | 1.36 |
| Employees | 174 | 43 |
| StockData Score | ||
| Total score | 5 | 5 |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 3 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 238× (better) | 2581× |
| P/B | 2.4× (better) | 162× |
| FCF yield | −16.8% | – |
| Growth | ||
| Revenue growth (TTM) | 9.0% (better) | −6.8% |
| Profitability | ||
| Gross margin | 75.8% (better) | −386% |
| Operating margin | −4880% (better) | −11411% |
| Net margin | −4637% (better) | −11305% |
| FCF margin | −4008% | – |
| Return on equity | −93.8% | – |
| Return on invested capital | −3856% | – |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.00 |
| Interest coverage | −615.2× | – |
| Current ratio | 12.45 (better) | 1.73 |
| Altman Z-score | 6.59 (better) | −6.04 |
| Piotroski F-score | 1 | 2 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −5.7% |
| Shareholder yield | 0.00% (better) | −5.7% |
| Ownership | ||
| Held by institutions | 70.8% | 39.7% |
| Held by insiders | 32.6% | – |
| Insider net buying, 12 months | $44.1M (better) | $8.2M |
| Short interest, % of float | 13.8% | – |
Go deeper
- AVR stock overview
- AVR income statement
- AVR valuation and score
- COCH stock overview
- COCH income statement
- COCH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.